Derangement of cardiac energetics contributes to the progression to heart failure

被引:0
|
作者
Sano, Motoaki
Fukuda, Keiichi
Izumi, Yasukatsu
Schneider, Michael D.
机构
[1] Keio Univ, Sch Med, Dept Regenerat Med & Advanced Cardiac Therapeut, Tokyo, Japan
[2] Baylor Coll Med, Ctr Cardiovasc Dev, Houston, TX 77030 USA
关键词
heart failure; metabolism; PGC-1;
D O I
10.1016/j.yjmcc.2006.08.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1040 / 1040
页数:1
相关论文
共 50 条
  • [31] In vivo 2D mapping of impaired murine cardiac energetics in NO-induced heart failure
    Floegel, Ulrich
    Jacoby, Christoph
    Goedecke, Axel
    Schrader, Juergen
    MAGNETIC RESONANCE IN MEDICINE, 2007, 57 (01) : 50 - 58
  • [32] Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure
    Golam M. Uddin
    Liyan Zhang
    Saumya Shah
    Arata Fukushima
    Cory S. Wagg
    Keshav Gopal
    Rami Al Batran
    Simran Pherwani
    Kim L. Ho
    Jamie Boisvenue
    Qutuba G. Karwi
    Tariq Altamimi
    David S. Wishart
    Jason R. B. Dyck
    John R. Ussher
    Gavin Y. Oudit
    Gary D. Lopaschuk
    Cardiovascular Diabetology, 18
  • [33] Pro-Inflammatory Derangement of the Immuno-Interactome in Heart Failure
    Kumar, Pavanish
    Lim, Amanda
    Poh, Su Li
    Hazirah, Sharifah Nur
    Chua, Camillus Jian Hui
    Sutamam, Nursyuhadah Binte
    Arkachaisri, Thaschawee
    Yeo, Joo Guan
    Kofidis, Theo
    Sorokin, Vitaly
    Lam, Carolyn S. P.
    Richards, Arthur Mark
    Albani, Salvatore
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [34] Calcium/Calmodulin-Dependent Protein Kinase II Contributes to Cardiac Arrhythmogenesis in Heart Failure
    Sag, Can M.
    Wadsack, Daniel P.
    Khabbazzadeh, Sepideh
    Abesser, Marco
    Grefe, Clemens
    Neumann, Kay
    Opiela, Marie-Kristin
    Backs, Johannes
    Olson, Eric N.
    Brown, Joan Heller
    Neef, Stefan
    Maier, Sebastian K. G.
    Maier, Lars S.
    CIRCULATION-HEART FAILURE, 2009, 2 (06) : 664 - 675
  • [35] Systemic iron deficiency does not affect the cardiac iron content and progression of heart failure
    Paterek, Aleksandra
    Okninska, Marta
    Chajduk, Ewelina
    Polkowska-Motrenko, Halina
    Maczewski, Michal
    Mackiewicz, Urszula
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2021, 159 : 16 - 27
  • [36] Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure
    Matsumoto, T
    Wada, A
    Tsutamoto, T
    Ohnishi, M
    Isono, T
    Kinoshita, M
    CIRCULATION, 2003, 107 (20) : 2555 - 2558
  • [37] Noninvasive Cardiac Imaging and the Prediction of Heart Failure Progression in Preclinical Stage A/B Subjects
    Gong, Fei Fei
    Campbell, Duncan J.
    Prior, David L.
    JACC-CARDIOVASCULAR IMAGING, 2017, 10 (12) : 1504 - 1519
  • [38] Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1
    Pathak, A
    del Monte, F
    Zhao, W
    Schultz, JE
    Lorenz, JN
    Bodi, I
    Weiser, D
    Hahn, H
    Carr, AN
    Syed, F
    Mavila, N
    Jha, L
    Qian, J
    Marreez, Y
    Chen, GL
    McGraw, DW
    Heist, EK
    Guerrero, JL
    DePaoli-Roach, AA
    Hajjar, RJ
    Kranias, EG
    CIRCULATION RESEARCH, 2005, 96 (07) : 756 - 766
  • [39] Protective Effects of Thyroid Hormone Deprivation on Progression of Maladaptive Cardiac Hypertrophy and Heart Failure
    Kerp, Helena
    Hoenes, Georg Sebastian
    Tolstik, Elen
    Hoenes-Wendland, Judith
    Gassen, Janina
    Moeller, Lars Christian
    Lorenz, Kristina
    Fuehrer, Dagmar
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [40] Persistent Hemodynamic Benefits of Cardiac Resynchronization Therapy With Disease Progression in Advanced Heart Failure
    Mullens, Wilfried
    Verga, Tanya
    Grimm, Richard A.
    Starling, Randall C.
    Wilkoff, Bruce L.
    Tang, W. H. Wilson
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (07) : 600 - 607